Elevated KIAA0101 expression is a marker of recurrence in human gastric cancer

Cancer Science

Volumn 104, Issue 3, 2013, Pages 353-359

  Zhu, Kun ^a   Diao, Dongmei ^a   Dang, Chengxue ^a   Shi, Lei ^a   Wang, Jianguang ^b   Yan, Rong ^a   Yuan, Dawei ^a   Li, Kang ^a  

^a THE FIRST AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

KIAA0101 PROTEIN; ONCOPROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER INVASION; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CELL NUCLEUS; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENE REPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NITROBLUE TETRAZOLIUM TEST; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RNA INTERFERENCE; STOMACH CANCER; SURVIVAL TIME;

CARRIER PROTEINS; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; RECURRENCE; STOMACH; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84874499318     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12083     Document Type: Article

References (28)

1. Crew KD, Neugut AI. Epidemiology of upper gastrointestinal malignancies. Semin Oncol 2004; 31: 450-64.
2. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225-49.
3. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006; 24: 2137-50.
4. Macdonald JS, Smalley SR, Benedetti J et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001; 345: 725-30.
5. Yu P, Huang B, Shen M et al. p15(PAF), a novel PCNA associated factor with increased expression in tumor tissues. Oncogene 2001; 20: 484-9.
6. Petroziello J, Yamane A, Westendorf L et al. Suppression subtractive hybridization and expression profiling identifies a unique set of genes overexpressed in non-small-cell lung cancer. Oncogene 2004; 23: 7734-45.
7. Mizutani K, Onda M, Asaka S et al. Overexpressed in anaplastic thyroid carcinoma-1 (OEATC-1) as a novel gene responsible for anaplastic thyroid carcinoma. Cancer 2005; 103: 1785-90.
8. Shi L, Zhang SL, Li K et al. NS5ATP9, a gene up-regulated by HCV NS5A protein. Cancer Lett 2008; 259: 192-7.
9. Li K, Ma Q, Shi L et al. NS5ATP9 gene regulated by NF-kappaB signal pathway. Arch Biochem Biophys 2008; 479: 15-9.
10. Kais Z, Barsky SH, Mathsyaraja H et al. KIAA0101 interacts with BRCA1 and regulates centrosome number. Mol Cancer Res 2011; 9: 1091-9.
11. Emanuele MJ, Ciccia A, Elia AE, Elledge SJ. Proliferating cell nuclear antigen (PCNA)-associated KIAA0101/PAF15 protein is a cell cycle-regulated anaphase-promoting complex/cyclosome substrate. Proc Natl Acad Sci U S A 2011; 108: 9845-50.
12. Simpson F, Lammerts van Bueren K, Butterfield N et al. The PCNA-associated factor KIAA0101/p15(PAF) binds the potential tumor suppressor product p33ING1b. Exp Cell Res 2006; 312: 73-85.
13. Turchi L, Fareh M, Aberdam E et al. ATF3 and p15PAF are novel gatekeepers of genomic integrity upon UV stress. Cell Death Differ 2009; 16: 728-37.
14. van Bueren KL, Bennetts JS, Fowles LF, Berkman JL, Simpson F, Wicking C. Murine embryonic expression of the gene for the UV-responsive protein p15(PAF). Gene Expr Patterns 2007; 7: 47-50.
15. Hosokawa M, Takehara A, Matsuda K et al. Oncogenic role of KIAA0101 interacting with proliferating cell nuclear antigen in pancreatic cancer. Cancer Res 2007; 67: 2568-76.
16. Notterman DA, Alon U, Sierk AJ, Levine AJ. Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res 2001; 61: 3124-30.
17. Kato T, Daigo Y, Aragaki M, Ishikawa K, Sato M, Kaji M. Overexpression of KIAA0101 predicts poor prognosis in primary lung cancer patients. Lung Cancer 2012; 75: 110-8.
18. Yuan RH, Jeng YM, Pan HW et al. Overexpression of KIAA0101 predicts high stage, early tumor recurrence, and poor prognosis of hepatocellular carcinoma. Clin Cancer Res 2007; 13: 5368-76.
19. American Joint Committee on Cancer (AJCC), 7th edn. Berlin, Germany: Springer Science and Business Media LLC, 2010.
20. Bravo R, Frank R, Blundell PA, Macdonald-Bravo H. Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature 1987; 326: 515-7.
21. Zhang Z, Shibahara K, Stillman B. PCNA connects DNA replication to epigenetic inheritance in yeast. Nature 2000; 408: 221-5.
22. Li R, Waga S, Hannon GJ, Beach D, Stillman B. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 1994; 371: 534-7.
23. Jain M, Zhang L, Patterson EE, Kebebew E. KIAA0101 is overexpressed, and promotes growth and invasion in adrenal cancer. PLoS ONE 2011; 6: e26866.
24. Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004; 429: 457-63.
25. Kolesnikova EV, Tamkovich SN, Bryzgunova OE et al. Circulating DNA in the blood of gastric cancer patients. Ann N Y Acad Sci 2008; 1137: 226-31.
26. Leung WK, To KF, Chu ES et al. Potential diagnostic and prognostic values of detecting promoter hypermethylation in the serum of patients with gastric cancer. Br J Cancer 2005; 92: 2190-4.
27. Miller WR. Clinical, pathological, proliferative and molecular responses associated with neoadjuvant aromatase inhibitor treatment in breast cancer. J Steroid Biochem Mol Biol 2010; 118: 273-6.
28. Guo M, Li J, Wan D, Gu J. KIAA0101 (OEACT-1), an expressionally down-regulated and growth-inhibitory gene in human hepatocellular carcinoma. BMC Cancer 2006; 6: 109.